AACR News: Studies show increasing evidence that androgen drives breast cancer
April 10, 2013 · Comments Off
Estrogen and progesterone receptors, and the gene HER2 – these are the big three markers and/or targets in breast cancer. Evidence presented at the AACR Annual Meeting 2013 adds a fourth: androgen receptors.
Longer life expectancy, aging population necessitate new strategies for prostate cancer care
December 4, 2012 · Comments Off
Members of the University of Colorado Cancer Center recently published a review in the journal Drugs and Aging describing the modern state of prostate cancer care – examining not only new drugs but entirely new classes of drugs that may be effective and well-tolerated in our aging population.
Clinical trial hits new target in war on breast cancer
December 3, 2012 · Comments Off
KEY POINTS: In addition to estrogen, progesterone and HER2, androgen drives breast cancer The drug...
Outliving the Odds
November 30, 2012 · Comments Off
In 20 years, Harry Peterson exhausts his doctor's 'Bag of Tricks," finds hope in a clinical trial.
Enzalutamide adds five months survival in late-stage prostate cancer
August 16, 2012 · Comments Off
Results of a phase III clinical trial of the drug Enzalutamide, published yesterday in the...
NTRK1: a new oncogene and target in lung cancer
August 16, 2012
alk drug lung cancer amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno biomarkers bladder cancer breast cancer cancer grants cancer research colorado Cancer Survivorship clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma metastasis microRNA Monique Spillman Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge screening skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
New tool developed at the CU Cancer Center helps doctors identify patients at highest risk of mortality --... http://t.co/RG1VMhAfyo
If you were planning to attend either our brain tumor support group at University of Colorado Hospital or our... http://t.co/Wsbl49jxag
New Cancer Center study shows active component of grape seed extract effective against cancer cells. http://t.co/nq2Cfar6an
C3 Magazine: Collaborating to Conquer Cancer Fall edition is here. Read stories about fingerprinting cancer, a... http://t.co/ce9xjCSHBi